• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-22-3p 通过靶向丝裂原活化蛋白激酶 14 调节阿尔茨海默病小鼠模型中的淀粉样 β 沉积。

MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.

机构信息

Department of Neurology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101100, China.

出版信息

Curr Neurovasc Res. 2019;16(5):473-480. doi: 10.2174/1567202616666191111124516.

DOI:10.2174/1567202616666191111124516
PMID:31713484
Abstract

UNLABELLED

Propose: To investigate whether miR-22-3p is able to regulate AD development and its molecular mechanism.

METHODS

Morris water maze test was performed to test the spatial memory. Quantitative polymerase chain reaction (qPCR) was used to assess the expression level of miR-22-3p. The enzymelinked immunosorbent assay (ELISA) was used to assess the levels of Aβ40 and Aβ42. Immunoblotting analysis was performed to detect the protein expression levels of amyloid precursor protein (APP), mitogen-activated protein kinase 14 (MAPK14) and beta-site Amyloid precursor protein Cleaving Enzyme 1 (BACE1). Luciferase assay was used to identify the interaction between miR- 22-3p and MAPK14. The tetrazolium dye (MTT) colorimetric assay was used to test the influence of miR-22-3p overexpression on cell viability. Flow cytometry analysis was performed to evaluate the effect of miR-22-3p overexpression on cell apoptosis.

RESULTS

Morris water maze test showed that mice model of AD had impaired spatial memory, which was able to be ameliorated by miR-22-3p overexpression. Immunoblotting analysis revealed that the protein expression levels of APP, MAPK14 and BACE1 were enhanced in AD model, which could be prevented by miR-22-3p overexpression. ELISA showed that Aβ40 and Aβ42 levels were dramatically increased in AD model, which were inhibited by miR-22-3p overexpression. Luciferase assay and immunoblotting analysis indicated that miR-22-3p targeted and regulated MAPK14 expression.

CONCLUSION

MiR-22-3p overexpression reduced Aβ deposit and alleviated AD symptoms by targeting and regulating MAPK14 expression, which ameliorated AD symptoms.

摘要

目的

探讨 miR-22-3p 是否能够调节 AD 的发生发展及其作用机制。

方法

采用 Morris 水迷宫实验检测空间记忆能力,实时定量聚合酶链式反应(qPCR)检测 miR-22-3p 的表达水平,酶联免疫吸附测定(ELISA)检测 Aβ40 和 Aβ42 水平,免疫印迹分析检测淀粉样前体蛋白(APP)、丝裂原活化蛋白激酶 14(MAPK14)和β 位淀粉样前体蛋白裂解酶 1(BACE1)的蛋白表达水平,荧光素酶报告基因实验鉴定 miR-22-3p 与 MAPK14 的靶向关系,四唑盐(MTT)比色法检测 miR-22-3p 过表达对细胞活力的影响,流式细胞术检测 miR-22-3p 过表达对细胞凋亡的影响。

结果

Morris 水迷宫实验结果显示 AD 模型小鼠的空间记忆受损,过表达 miR-22-3p 可改善 AD 模型小鼠的空间记忆能力。免疫印迹分析结果显示,AD 模型中 APP、MAPK14 和 BACE1 的蛋白表达水平升高,过表达 miR-22-3p 可抑制 AD 模型中 APP、MAPK14 和 BACE1 的蛋白表达水平。ELISA 结果显示,AD 模型中 Aβ40 和 Aβ42 水平显著升高,过表达 miR-22-3p 可降低 AD 模型中 Aβ40 和 Aβ42 水平。荧光素酶报告基因实验和免疫印迹分析结果表明,miR-22-3p 可靶向调控 MAPK14 的表达。

结论

过表达 miR-22-3p 通过靶向调控 MAPK14 表达减轻 AD 症状,减少 Aβ 沉积,改善 AD 症状。

相似文献

1
MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.miR-22-3p 通过靶向丝裂原活化蛋白激酶 14 调节阿尔茨海默病小鼠模型中的淀粉样 β 沉积。
Curr Neurovasc Res. 2019;16(5):473-480. doi: 10.2174/1567202616666191111124516.
2
MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.miR-335-5p 通过靶向 c-jun-N 末端激酶 3 抑制β-淀粉样蛋白(Aβ)积累,从而减轻阿尔茨海默病中的认知障碍。
Curr Neurovasc Res. 2020;17(1):93-101. doi: 10.2174/1567202617666200128141938.
3
Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.淀粉样β斑块形成和反应性神经胶质增生是 APP 敲入阿尔茨海默病小鼠模型认知缺陷诱导所必需的。
BMC Neurosci. 2019 Mar 20;20(1):13. doi: 10.1186/s12868-019-0496-6.
4
MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.微小RNA-361-3p通过靶向β-分泌酶1抑制阿尔茨海默病中的β-淀粉样蛋白积累并减轻认知缺陷。
J Integr Neurosci. 2019 Sep 30;18(3):285-291. doi: 10.31083/j.jin.2019.03.1136.
5
MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.miRNA-128 敲除通过靶向 PPARγ 抑制小鼠模型阿尔茨海默病的发展。
Eur J Pharmacol. 2019 Jan 15;843:134-144. doi: 10.1016/j.ejphar.2018.11.004. Epub 2018 Nov 6.
6
miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.miR-29c-3p 通过调控β-淀粉样前体蛋白裂解酶 1 减轻阿尔茨海默病中的β-淀粉样蛋白诱导的神经毒性。
Physiol Res. 2023 Dec 31;72(6):833-841. doi: 10.33549/physiolres.935084.
7
Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.新型 microRNA-455-3p 及其对阿尔茨海默病中异常 APP 处理和淀粉样 β 毒性的保护作用。
Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2428-2440. doi: 10.1016/j.bbadis.2019.06.006. Epub 2019 Jun 8.
8
Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.叶酸缺乏会增强 APP/PS1 小鼠大脑中β淀粉样蛋白的积累,并降低与淀粉样蛋白相关的微小核糖核酸的表达。
J Nutr Biochem. 2015 Dec;26(12):1502-8. doi: 10.1016/j.jnutbio.2015.07.020. Epub 2015 Aug 8.
9
Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer's disease.miR-132-3p 的过表达有助于阿尔茨海默病体外和体内模型中的神经元保护。
Behav Brain Res. 2022 Jan 24;417:113584. doi: 10.1016/j.bbr.2021.113584. Epub 2021 Sep 15.
10
MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.miR-340 通过靶向 BACE1(β-淀粉样前体蛋白裂解酶 1)减少阿尔茨海默病中淀粉样β的积累。
Curr Neurovasc Res. 2020;17(1):86-92. doi: 10.2174/1567202617666200117103931.

引用本文的文献

1
Circ_0049472 downregulation relieves Amyloid-β-induced neuronal injury by modulating PDE4A expression via targeting miR-22-3p in Alzheimer's disease.在阿尔茨海默病中,Circ_0049472的下调通过靶向miR-22-3p调节PDE4A表达来减轻淀粉样β蛋白诱导的神经元损伤。
Metab Brain Dis. 2025 Aug 29;40(7):252. doi: 10.1007/s11011-025-01652-4.
2
Per- and polyfluoroalkyl substances (PFAS) and microRNA: An epigenome-wide association study in firefighters.全氟和多氟烷基物质(PFAS)与微小RNA:消防员的全表观基因组关联研究
Environ Res. 2025 Aug 15;279(Pt 2):121766. doi: 10.1016/j.envres.2025.121766. Epub 2025 May 9.
3
Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer's Disease.
微小RNA对细胞凋亡途径的调控:一种治疗阿尔茨海默病的策略。
Mol Neurobiol. 2025 Apr 12. doi: 10.1007/s12035-025-04833-5.
4
Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases.不同神经退行性疾病中细胞外囊泡分子货物的共同和独特变化。
Cell Mol Life Sci. 2024 Dec 3;81(1):479. doi: 10.1007/s00018-024-05522-7.
5
MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy.微小 RNA:阿尔茨海默病发病机制、诊断和治疗的先驱调控因子。
Transl Psychiatry. 2024 Sep 10;14(1):367. doi: 10.1038/s41398-024-03075-8.
6
Tanshinone IIA improves Alzheimer's disease RNA nuclear-enriched abundant transcript 1/microRNA-291a-3p/member RAS oncogene family Rab22a axis.丹参酮IIA改善阿尔茨海默病RNA核富集丰富转录本1/微小RNA-291a-3p/RAS癌基因家族成员Rab22a轴。
World J Psychiatry. 2024 Apr 19;14(4):563-581. doi: 10.5498/wjp.v14.i4.563.
7
Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.超越 CSF 和神经影像学评估:评估血浆 miR-145-5p 作为轻度认知障碍和阿尔茨海默病潜在生物标志物的研究。
ACS Chem Neurosci. 2024 Mar 6;15(5):1042-1054. doi: 10.1021/acschemneuro.3c00740. Epub 2024 Feb 26.
8
MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.微小RNA-22-3p从5'非翻译区取代关键宿主因子并抑制柯萨奇病毒B3 RNA的翻译。
J Virol. 2024 Feb 20;98(2):e0150423. doi: 10.1128/jvi.01504-23. Epub 2024 Jan 30.
9
Alzheimer's Disease: Models and Molecular Mechanisms Informing Disease and Treatments.阿尔茨海默病:为疾病与治疗提供信息的模型和分子机制
Bioengineering (Basel). 2024 Jan 1;11(1):45. doi: 10.3390/bioengineering11010045.
10
NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease.非编码RNA:阿尔茨海默病中一种协同抗凋亡的治疗工具。
CNS Neurosci Ther. 2024 Apr;30(4):e14476. doi: 10.1111/cns.14476. Epub 2023 Sep 22.